Key clinical point: Sickle cell disease patients appear to be at lower risk for opioid-related mortality than the general U.S. population.
Major finding: While the rate of inpatient death from opioid overdose rose 350% among the general U.S. population from 1998 to 2013, it remained essentially at zero among patients with sickle cell disease.
Study details: A retrospective analysis of discharge diagnoses from the National Inpatient Sample from 1998 to 2013.
Disclosures: The researchers reported having no relevant financial disclosures.
Akinboro OA et al. ASH 2018, Abstract 315.
Must Reads in Anemia
Gene therapy reverses sickle cell phenotype in small study, Esrick EB et al. ASH 2018, Abstract 1023
Sickle cell pain: Opioids appear safe for inpatients, Akinboro OA et al. ASH 2018, Abstract 315
Sickle cell: Daily hydroxyurea safe in African children, Tshilolo L et al. ASH 2018, Abstract 3